Scientific rationale for the use of α2A-adrenoceptor agonists in treating neuroinflammatory cognitive disorders

AFT Arnsten, Y Ishizawa, Z **e - Molecular Psychiatry, 2023 - nature.com
Neuroinflammatory disorders preferentially impair the higher cognitive and executive
functions of the prefrontal cortex (PFC). This includes such challenging disorders as …

Scientific rationale for the treatment of cognitive deficits from long COVID

A Fesharaki Zadeh, AFT Arnsten, M Wang - Neurology International, 2023 - mdpi.com
Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but
currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral …

Localization of PDE4D, HCN1 channels, and mGluR3 in rhesus macaque entorhinal cortex may confer vulnerability in Alzheimer's disease

D Datta, I Perone, YM Morozov, J Arellano… - Cerebral …, 2023 - academic.oup.com
Alzheimer's disease cortical tau pathology initiates in the layer II cell clusters of entorhinal
cortex, but it is not known why these specific neurons are so vulnerable. Aging macaques …

[HTML][HTML] Stress and inflammation target dorsolateral prefrontal cortex function: Neural mechanisms underlying weakened cognitive control

MKP Joyce, S Uchendu, AFT Arnsten - Biological Psychiatry, 2024 - Elsevier
Most mental disorders involve dysfunction of the dorsolateral prefrontal cortex (dlPFC), a
recently evolved brain region that subserves working memory, abstraction and the thoughtful …

Biomaterial strategies for regulating the neuroinflammatory response

AN Galindo, DAF Rubio, MH Hettiaratchi - Materials Advances, 2024 - pubs.rsc.org
Injury and disease in the central nervous system (CNS) can result in a dysregulated
inflammatory environment that inhibits the repair of functional tissue. Biomaterials present a …

Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy

F Zhang, Z Zhang, J Alt, SP Kambhampati… - Journal of Controlled …, 2023 - Elsevier
Glutamate carboxypeptidase II (GCPII), localized on the surface of astrocytes and activated
microglia, regulates extracellular glutamate concentration in the central nervous system …

Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques

S Bathla, D Datta, F Liang, N Barthelemy… - … Research & Clinical …, 2023 - Wiley Online Library
Introduction Current approaches for treating sporadic Alzheimer's disease (sAD) focus on
removal of amyloid beta 1‐42 (Aβ1‐42) or phosphorylated tau, but additional strategies are …

Experimental approaches for altering the expression of Abeta‐degrading enzymes

DA Loeffler - Journal of neurochemistry, 2023 - Wiley Online Library
Cerebral clearance of amyloid β‐protein (Aβ) is decreased in early‐onset and late‐onset
Alzheimer's disease (AD). Aβ is cleared from the brain by enzymatic degradation and by …

Nanoscale imaging of pT217‐tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early‐stage …

D Datta, I Perone, D Wijegunawardana… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Tau phosphorylated at threonine‐217 (pT217‐tau) is a novel fluid‐based
biomarker that predicts onset of Alzheimer's disease (AD) symptoms, but little is known …

Neuropsychiatric Manifestations of COVID-19 Disease and Post Covid Syndrome: The Role of N Acetyl-cysteine and Acetyl-L-carnitine

T Barlattani, G Celenza, A Cavatassi… - Current …, 2024 - benthamdirect.com
COVID-19 is associated with neuropsychiatric symptoms, such as anosmia, anxiety,
depression, stress-related reactions, and psychoses. The illness can cause persistent …